Andrey, a lawyer in the firm’s Capital Market Department, specializes in advising private and public companies, with an emphasis on dual companies.
Andrey regularly accompanies Israeli and foreign companies in the areas of capital markets, commercial law, public offerings, mergers and acquisitions, joint ventures, and corporate governance. He also represents the firm’s clients before the Israel Securities Authority.
In addition, Andrey accompanies blockchain technology companies in all aspects of their commercial activities, including the issuance of digital currencies of all kinds (ICOs and STOs), intellectual property, technology commercialization, and privacy.
Prior to joining the firm, Andrey worked at the Bank of Israel, where he accompanied structural reforms and regulatory processes in the banking and capital market fields.
Tel-Aviv University (LL.B, BA in economics) 2010
Member of the Israel Bar Association since 2011
News and updates - Andrey Yanai:
Medigus Ltd. Completed a Nasdaq IPO
Barnea & Co. represented a group of US underwriters, led by H.C. Wainwright & Co., LLC, in the process of submission of Medigus Ltd. of a prospectus for the Nasdaq listing. Medigus raised USD 7.5 million and will be traded on Nasdaq in parallel with its listing on the Tel Aviv Stock Exchange. Medigus Ltd is an Israel-based company active in the medical sector. It specializes in developing endoscopic procedures and devices.
Cellect Biotechnology Completed a Nasdaq IPO
On 31st July 2016 Cellect Biotechnology announced that it has completed its Nasdaq IPO, raising $8.4 million. Cellect Biotechnology will be traded on Nasdaq in parallel with its listing on the Tel Aviv Stock Exchange. Barnea & Co. represented a group of US underwriters, led by H.C. Wainwright & Co., LLC, in the process of submission by Cellect Biotechnology of a prospectus for the Nasdaq listing. Cellect Biotechnology develops innovative technologies in the stem cells sphere.
Proposal to reconsider the activist regulatory model of the Israel Securities Authority
An article by Adv. Zvi Gabbay and Andrey Yanai on the proposal to reconsider the activist regulatory model of the Israel Securities Authority applied to the public companies, allowing them to enjoy wider business and legal maneuvering room.